To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
Out-of-pocket costs for Medicare beneficiaries are rising. It's time for policymakers to act.
Why do some patients so much more?
What began as a safeguard against unnecessary drug spending has become a significant barrier to patient access.
Innovation comes at a price, one that health insurers may hesitate to pay.
Learn more about the insurance practice called step therapy.